Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment
Authors:
- 16 March 2005
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 84 (7) , 456-461
Abstract
Autologous peripheral blood stem cell transplantation is performed in an increasing number of chronic lymphocytic leukaemia (CLL) patients who are in the first remission following fludarabine treatment. There are contradictory data about the adverse impact of fludarabine on stem cell harvest. We analysed retrospectively mobilization results in 56 poor-risk CLL patients (median age: 56 years) who underwent first-line treatment with fludarabine and cyclophosphamide. The mobilization, consisting of cyclophosphamide 3 g/m2 and granulocyte colony-stimulating factor (G-CSF) 10 μg/kg per day, was performed with a median of 77 days following the last fludarabine course. The target yield was ≥2.0×106 CD34+ cells/kg. The procedure was successful in 23 (41%) patients. A median of 3.3×106 CD34+ cells/kg was collected per patient. The successful mobilization was associated with a longer interval from the last chemotherapy (>2 months). The mobilization result was not influenced by the number of fludarabine cycles. No correlation was found in other parameters such as disease stage at diagnosis, disease status at stimulation or age. The poorly mobilized patients had significantly lower prestimulation blood counts (platelets, WBC and haemoglobin). Our data show that fludarabine does not generally prevent the stem cell mobilization; nevertheless, mechanisms related to the impact of fludarabine on stem cell harvest must be further investigated.Keywords
This publication has 19 references indexed in Scilit:
- Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemiaBlood, 2004
- Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1HLeukemia, 2003
- It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvementBritish Journal of Haematology, 2003
- Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemiaLeukemia, 2002
- “Fludarabine Containing-Regimens May Adversely Affect Peripheral Blood Stem Cell Collection in Low-Grade Non Hodgkin Lymphoma Patients”Leukemia & Lymphoma, 2000
- Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin’s lymphomas and Hodgkin’s diseaseBone Marrow Transplantation, 1999
- Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationBone Marrow Transplantation, 1999
- PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemiaBone Marrow Transplantation, 1998
- Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yieldBone Marrow Transplantation, 1997
- Optimization of Peripheral Blood Stem Cell MobilizationStem Cells, 1996